Eyal C. Attar

Eyal C. Attar is a declared insider at 2 companies; the most frequent names are Vor Biopharma Inc. and Aprea Therapeutics, Inc. We count 23 filings; the first trade dates from 25 August 2021 and the latest from 13 February 2025.

Every open-market trade on record is a sale: 6 sales worth €157k. Outside the open market, there are 17 share grants. In 2025 alone, the filings show no purchases and 2 sales.

The record was last updated on 18 February 2025 with an open-market sale (€3,043) in Vor Biopharma Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.